Ora Oxford University Research Archivemetadata only
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
archives, research
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 215714
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.